SCIENTIFIC HIGHLIGHTS
| Thursday, 4th September 2025 | |||
|---|---|---|---|
| Time | Topic 1 | Topic 2 | Topic 3 |
| 9 am - 12 noon | Gender incongruence | Nuclear imaging in Endocrinology beyond thyroid | Imaging - Pituitary, adrenal and parathyroid |
| 1 pm to 4 pm | Insulin pump | Diabetic foot | Advanced DXA |
Seats for workshops limited, on first-come-first-served basis.
For participation, registration as conference delegate is mandatory.
| Oration | Speaker(s) |
|---|---|
| Presidential Oration | Lt Gen (Dr) Narendra Kotwal (Paras Hospital, Panchkula) |
| Dr MMS Ahuja Memorial Oration | Dr Rishi Shukla (Regency Hospital, Kanpur) |
| Dr Subhas Mukherjee Memorial Oration | Prof Pinaki Dutta (PGIMER Chandigarh) |
| Dr P N Shah Memorial Oration | Prof Rama Walia (PGIMER Chandigarh) |
| Topic | Speaker |
|---|---|
| Management of Idiopathic Adrenal hyperplasia: An update | Anurag Lila |
| Molecular imaging in the diagnosis of Cushing Syndrome: Present and Future | Remya Rajan R |
| Cushing’s disease after failed trans-sphenoidal surgery: How should I approach | Asha H.S. |
| Challenges with BIPSS: A case-based approach | M.K. Garg |
| Role of nuclear imaging in primary aldosteronism | Kishore Kumar Behera |
| Imaging in Insulinoma: An update | Bipin Kumar Sethi |
| Hypophysitis: Endocrine kaleidoscope | Tushar Bandgar |
| Pituitary Apoplexy: Endocrine kaleidoscope | Prem Narayanan |
| Hypothalamic Syndrome | S. Sridhar |
| Sheehan Syndrome | Zargar A.H. |
| Newer therapies in Acromegaly | S K Singh |
| Idiopathic short stature: Myth or Reality? | V. Sri Nagesh |
| What’s in a name? Pit adenoma or Pit NET | Riaz Ahmad Misgar |
| Surgery in Prolactinoma: When? Why? | K V S Harikumar |
| Pituitary micro-incidentaloma | Alok Sachan |
| Persistent hyperprolactinemia & negative sellar imaging | Anil Bhansali |
| Aggressive NFPA | Sadishkumar Kamalanathan |
| Spectrum of primary adrenal insufficiency in childhood | Abhamoni Baro |
| Enigmatic adrenal SOLs | Gagan Priya |
| Ectopic Cushing’s: Diagnostic and therapeutic challenges | Umesh Kumar Garg |
| Elevated metanephrine(s), negative imaging: What should we do? | Nalini Shah |
| Power of innovation of new generation insulins: Advancing from Human insulins | Unnikrishnan AG |
| A SOUL- ful perspective on oral Semaglutide | Shashank R Joshi |
| One STEP ahead - Unlocking the full potential of Semaglutide 2.4 mg | Sanjay Kalra |
| Advancing the management of CVD in people living with Obesity | Krishna Seshadri |
| Exploring GIP-GLP1 co-agonism with Tirzepatide | Ganapati Bantwal |
| PRA v/s DRC - assay variations and clinical utility | Nikhil Bhagwat |
| Role of Machine learning in Type 1 diabetes | Rajiv Singla |
| Management of dyslipidemia in pregnancy: "Benefits" vs "Risks" | Rama Mohan |
| Critical illness related adrenal insufficiency | Beatrice Anne |
| Fertility prospects in adults with CYP21A2 defect | Shriraam Mahadevan |
| Post Pituitary surgery polyuria: How to approach | Basavaraj Sooragonda |
| Nelson syndrome: From prediction to prevention | Jay Chordia |
| Topic | Speaker |
|---|---|
| CAH management across lifespan | Manjiri Karlekar |
| AMH across lifespan | Belinda George |
| Normohormonal Hyperparathyroidism: An expanding horizon | Dinesh Kumar Dhanwal |
| Normocalcemic hyperparathyroidism: An update | Sanjay Kumar Bhadada |
| Imaging in osteoporosis: beyond DXA | Satinath Mukhopadhyay |
| Genetics in Primary Hyperparatyroidism: An update | Parjeet Kaur |
| Hypoparathyroidism: Treatment target and challenges | Pramod Gandhi |
| The kaleidoscope of Medullary thyroid carcinoma | Jayaprakash Sahoo |
| Combination therapy of T4+T3: Hype or hope? | Deep Dutta |
| From bench side to bed side: Low-risk Papillary thyroid carcinoma | Dukhabandu Naik |
| 11-year-old boy with gynecomastia: How to approach | P K Jabbar |
| Child with ambiguous genitalia and palpable gonads: Approach | Vijayasarathi |
| 1 year old girl with isolated thelarche: how to approach | Nisha Bhavani |
| Drug induced alterations in TFT | Ipsita Mishra |
| Drug induced hyperprolactinemia | Uma Kaimal Saikia |
| Drug induced adrenal insufficieincy | Nilakshi Deka |
| CKD-MBD: From an Endocrinologist's perspective | Ameya Joshi |
| TmP/GFR: A critical appraisal | Prathosh Gangadhar |
| Sclerotic bone disorders: Role of imaging to reach the etiology | S. Ramkumar |
| Osteomorphs and its role in osteoporosis | Swayamsidha Mangaraj |
| Glucocorticoid induced osteoporosis | Sachin Chittawar |
| Hungry bone syndrome: Prevention and management | Soham Mukhejee |
| Diabetic Osteopathy | Ambrish Mithal |
| Tumour induced osteomalacia | Sanjay Saran |
| Optimal serum 25OHD | Raman Marwaha |
| Non-compliance with LT4 | Nikhil Tandon |
| Non-compliance with thionamide | Subrahmanyam KAV |
| Anti-TSHRAb in routine practice | Arun Menon C.S |
| Evidence-based Management: Hypertension in diabetes | Abhay Kumar Sahoo |
| Evidence based management: Primary and secondary prevention of CKD in diabetes | Balram Sharma |
| Guidelines to Clinical practice: LDL-c in diabetes | Deepak Khandelwal |
| Guidelines to Clinical practice: TG in diabetes | Jayabhanu Kanwar |
| Guidelines to Clinical practice: Lp(a) in diabetes | Jaideep Khare |
| Surgical fitness in patients with diabetes | Prem Prakash Patidar |
| Surgical fitness in patients with abnormal TFT | Saptarshi Bhattacharya |
| Steroid induced Hyperglycemia: Management strategies | Om Jitendra Lakhani |
| Asymptomatic hyperuricemia in Diabetes | Sameer Aggarwal |
| Management of Diabetes in patients with CLD | S K Wangnoo |
| New clusters of Diabetes: ‘What’s different’ | Riddhi Dasgupta |
| Type 5 diabetes: New wine in an old bottle | Nihal Thomas |
| Post transplantation diabetes mellitus | Suresh Damodaran |
| Approach to indeterminate thyroid nodule | Subramanian Kannan |
| Thyroid hormone assay interference | Vijay Bhaskar Reddy |
| Osteosarcopenia: Clinical significance | Muthukrishnan |
| Topic | Speaker |
|---|---|
| PCOS: Implementing Guidelines into practice | Ashraf Ganie Mohd |
| Management of adults with Turner syndrome | Yashdeep Gupta |
| Genetics of Turner syndrome | Naincy Purwar |
| Evaluation of the GH-IGF1 axis: potential pitfalls | Vageesh Ayyar |
| Long-acting growth hormone Preparations: Current status and future considerations | H.K Ganesh |
| Ovulation induction in PCOS: Current perspectives | Preeti Dabadghao |
| “Timing hypothesis” and post-menopausal hormone therapy | Jayashree Swain |
| Myoinositol in PCOS: Is it really effective | Chitra Selvan |
| Approach to a child with recurrent fractures | Sushil Gupta |
| Resistant rickets: Diagnostic algorithm | Rajesh Khadgawat |
| Childhood obesity: Clinical approach | Sambit Das |
| Tumor risk in DSD: What we have learnt? | Raju A Gopal |
| Genetics in DSD in resource-restricted settings: When? What? | Jayashree Gopal |
| Fruitful or futile? CDGP Vs. Hypo hypo | Sushil Jindal |
| Clinical spectrum of IHH | Nishant Raizada |
| Pubertal induction and maintenance in male with IHH: An update | Madhukar Mittal |
| Reversal of IHH: Myth or reality? | Santosh Kumar Singh |
| Early Vs. late GDM: What is the difference? | Alpesh Goyal |
| Metformin in diabetes in pregnancy: What we have learnt? | Prakash Keshwani |
| Offspring of pregnant women with diabetes | Sarita Bajaj |
| Approach to young onset, lean, non ketotic Diabetes | Shivprasad C |
| Mortality in Type 1 DM: what we have learnt | SV Madhu |
| Screening for monogenic diabetes in patients with type 1 diabetes | Eesh Bhatia |
| Disease modifying agents: Can we prevent T1DM? | George Joe |
| Non-insulin therapy in Type 1 Diabetes | Mohan Shenoy |
| β cell replacement in T1D: Advancements and obstacles | Ravindra Sukla |
| Adiposopathy: A disease for South Asians? | Sandeep Mathur |
| Inceptors in diabetes: A new breakthrough? | Aneesh Ghosh MS |
| Spectrum of diabetic cystopathy | Manas P. Baruah |
| Diabetes distress: Concerns and struggles | Tejal Lathia |
Anil R Sheth Award paper presentations(in Clinical Endocrinology and in
Basic/Comparative
Endocrinology)
Instituted in the memory of Dr Anil R Sheth, one of the senior members of ESI and its
past
Secretary and Vice President, these awards are primarily aimed at recognising the
younger
ESI
members conducting original research work in India.
Dedicated half-day sessions featuring cutting-edge updates, case discussions and practical insights in
| Specialty | Date |
|---|---|
| Bone and mineral endocrinology (for orthopaedic surgeons / rheumatologists / physiatrists) |
6th September 2025 |
| Reproductive endocrinology (for gynaecologists) |
7th September 2025 |
| Paediatric Endocrinology (for paediatricians) |
7th September 2025 |
All delegates for the half-day sessions will receive certificates of participation but will not qualify for CME credit points.
And many more!!!
Join us for the scientific cornucopia across the length and breadth of Endocrinology between 4th-7th September 2025, at ITC Royal Bengal Kolkata.